Reaction of Mycobacterium tuberculosis Cytochrome P450 enzymes with nitric oxide

Biochemistry

Volumn 48, Issue 5, 2009, Pages 863-872

  Ouellet, Hugues ^a   Lang, Jérôme ^b   Couture, Manon ^b   De Montellano, Paul R Ortiz ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANAEROBIC REDUCTIONS; CYTOCHROME OXIDASE; CYTOCHROME P-450; HEME PROTEINS; INHIBITORY EFFECTS; MYCOBACTERIUM TUBERCULOSIS; N-O COMPLEXES; PHYSIOLOGICAL CONCENTRATIONS; RESONANCE RAMAN; SODIUM DITHIONITE; STOPPED FLOWS; UV-VISIBLE ABSORPTIONS;

CATALYSTS; ENZYMES; HEMOGLOBIN; NITRIC OXIDE; PORPHYRINS; SODIUM;

ABSORPTION SPECTROSCOPY;

CYTOCHROME P450; CYTOCHROME P450 125; CYTOCHROME P450 130; CYTOCHROME P450 142; FERRIC ION; FERROUS ION; NITRIC OXIDE; NITRITE REDUCTASE; SODIUM DITHIONITE; STEROL 14ALPHA DEMETHYLASE; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; CYP130 PROTEIN, M TUBERCULOSIS; CYTOCHROME P 450 CYP51, MYCOBACTERIUM TUBERCULOSIS; CYTOCHROME P-450 CYP51, MYCOBACTERIUM TUBERCULOSIS; REACTIVE NITROGEN SPECIES; RECOMBINANT PROTEIN;

ARTICLE; CONTROLLED STUDY; ENZYME BINDING; ENZYME INHIBITION; ENZYME PURIFICATION; ESCHERICHIA COLI; MOLECULAR CLONING; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BIOSYNTHESIS; CATTLE; COMPARATIVE STUDY; ENZYMOLOGY; GROWTH, DEVELOPMENT AND AGING; HORSE; METABOLISM; PROTEIN BINDING;

MYCOBACTERIUM TUBERCULOSIS;

ANIMALS; BACTERIAL PROTEINS; CATTLE; CYTOCHROME P-450 ENZYME SYSTEM; FERRIC COMPOUNDS; HORSES; MYCOBACTERIUM TUBERCULOSIS; NITRIC OXIDE; PROTEIN BINDING; REACTIVE NITROGEN SPECIES; RECOMBINANT PROTEINS;

EID: 61449218869     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi801595t     Document Type: Article

References (53)

1. Toossi, Z., and Ellner, J. J. (2000) Pathogenesis of tuberculosis. Tuberculosis: Current Concepts and Treatment, 19-47.
2. Chan, E. D., Chan, J., and Schluger, N. W. (2001) What is the role of nitric oxide in murine and human host defense against tuberculosis? Current knowledge. Am. J. Respir. Cell Mol. Biol. 25, 606-612.
3. Flynn, J. L., and Chan, J. (2003) Immune evasion by Mycobacterium tuberculosis: living with the enemy. Curr. Opin. Immunol. 15, 450-455.
4. Long, R., Light, B., and Talbot, J. A. (1999) Mycobacteriocidal action of exogenous nitric oxide. Antimicrob. Agents Chemother. 43, 403-405.
5. Gow, A. J., Foust, R., Malcolm, S., Gole, M., and Ischiropoulos, H. (1999) Biochemical regulation of nitric oxide toxicity. Nitric Oxide and Infection, 175-187.
6. Brunori, M. (2001) Nitric oxide, cytochrome-c oxidase and myoglobin. Trends Biochem. Sci. 26, 21-23.
7. Pfeiffer, S., Gorren, A. C., Schmidt, K., Werner, E. R., Hansert, B., Bohle, D. S., and Mayer, B. (1997) Metabolic fate of peroxynitrite in aqueous solution. Reaction with nitric oxide and pH-dependent decomposition to nitrite and oxygen in a 2:1 stoichiometry. J. Biol. Chem. 272, 3465-3470.
8. Nathan, C., and Shiloh, M. U. (2000) Reactive oxygen and nitrogen intermediates in the relationship between mammalian hosts and microbial pathogens. Proc. Natl. Acad. Sci. U.S.A. 97, 8841-8848.
9. Alexander, B. (1998) The role of nitric oxide in hepatic metabolism. Nutrition 14, 376-390.
10. Donato, M. T., Guillen, M. I., Jover, R., Castell, J. V., and Gomez-Lechon, M. J. (1997) Nitric oxide-mediated inhibition of cytochrome P450 by interferon-gamma in human hepatocytes. J. Pharmacol. Exp. Ther. 281, 484-490.
11. Cole, S. T., Brosch, R., Parkhill, J., Garnier, T., Churcher, C., Harris, D., Gordon, S. V., Eiglmeier, K., Gas, S., Barry, C. E., III, Tekaia, F., Badcock, K., Basham, D., Brown, D., Chillingworth, T., Connor, R., Davies, R., Devlin, K., Feltwell, T., Gentles, S., Hamlin, N., Holroyd, S., Hornsby, T., Jagels, K., Krogh, A., McLean, J., Moule, S., Murphy, L., Oliver, K., Osborne, J., Quail, M. A., Rajandream, M. A., Rogers, J., Rutter, S., Seeger, K., Skelton, J., Squares, R., Squares, S., Sulston, J. E., Taylor, K., Whitehead, S., and Barrell, B. G (1998) Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393, 537-544.
12. McLean, K. J., and Munro, A. W. (2008) Structural biology and biochemistry of cytochrome P450 systems in Mycobacterium tuberculosis. Drug Metab. Rev. 40, 427-446.
13. Bellamine, A., Mangla, A. T., Nes, W. D., and Waterman, M. R. (1999) Characterization and catalytic properties of the sterol 14alpha-demethylase from Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U.S.A. 96, 8937-8942.
14. Van der Geize, R., Yam, K., Heuser, T., Wilbrink, M. H., Hara, H., Anderton, M. C., Sim, E., Dijkhuizen, L., Davies, J. E., Mohn, W. W., and Eltis, L. D. (2007) A gene cluster encoding cholesterol catabolism in a soil actinomycete provides insight into Mycobacterium tuberculosis survival in macrophages. Proc. Natl. Acad. Sci. U.S.A. 104, 1947-1952.
15. Chang, J. C., Harik, N. S., Liao, R. P., and Sherman, D. R. (2007) Identification of mycobacterial genes that alter growth and pathology in macrophages and in mice. J. Infect. Dis. 196, 788-795.
16. Rengarajan, J., Bloom, B. R., and Rubin, E. J. (2005) Genomewide requirements for Mycobacterium tuberculosis adaptation and survival in macrophages. Proc. Natl. Acad. Sci. U.S.A. 102, 8327-8332.
17. Leys, D., Mowat, C. G., McLean, K. J., Richmond, A., Chapman, S. K., Walkinshaw, M. D., and Munro, A. W. (2003) Atomic structure of Mycobacterium tuberculosis CYP121 to 1.06 A reveals novel features of cytochrome P450. J. Biol. Chem. 278, 5141-5147.
18. Ouellet, H., Podust, L. M., and de Montellano, P. R. (2008) Mycobacterium tuberculosis CYP130: crystal structure, biophysical characterization, and interactions with antifungal azole drugs. J. Biol. Chem. 283, 5069-5080.
19. Seward, H. E., Roujeinikova, A., McLean, K. J., Munro, A. W., and Leys, D. (2006) Crystal structure of the Mycobacterium tuberculosis P450 CYP121-fluconazole complex reveals new azole drug-P450 binding mode. J. Biol. Chem. 281, 39437-39443.
20. Podust, L. M., Poulos, T. L., and Waterman, M. R. (2001) Crystal structure of cytochrome P450 14alpha-sterol demethylase (CYP51) from Mycobacterium tuberculosis in complex with azole inhibitors. Proc. Natl. Acad. Sci. U.S.A. 98, 3068-3073.
21. Gegner, J. A., and Dahlquist, F. W. (1991) Signal transduction in bacteria: CheW forms a reversible complex with the protein kinase CheA. Proc. Natl. Acad. Sci. U.S.A. 88, 750-754.
22. Omura, T., and Sato, R. (1964) The carbon monoxide-binding pigment of liver microsomes. I. Evidence for its hemoprotein nature. J. Biol. Chem. 239, 2370-2378.
23. Chartier, F. J., and Couture, M. 2004) Stability of the heme environment of the nitric oxide synthase from Staphylococcus aureus in the absence of pterin cofactor. Biophys. J. 87, 1939-1950.
24. McLean, K. J., Dunford, A. J., Sabri, M., Neeli, R., Girvan, H. M., Balding, P. R., Leys, D., Seward, H. E., Marshall, K. R., and Munro, A. W. (2006) CYP121, CYP51 and associated redox systems in Mycobacterium tuberculosis: towards deconvoluting enzymology of P450 systems in a human pathogen. Biochem. Soc. Trans. 34, 1178-1182.
25. Couture, M., Adak, S., Stuehr, D. J., and Rousseau, D. L. (2001) Regulation of the properties of the heme-NO complexes in nitric-oxide synthase by hydrogen bonding to the proximal cysteine. J. Biol. Chem. 276, 38280-38288.
26. Yoshimura, T., and Ozaki, T. (1984) Electronic spectra for nitrosyl(protoporphyrin IX dimethyl ester)iron(II) and its complexes with nitrogenous bases as model systems for nitrosylhemoproteins. Arch. Biochem. Biophys. 229, 126-135.
27. Nakano, R., Sato, H., Watanabe, A., Ito, O., and Shimizu, T. (1996) Conserved Glu318 at the cytochrome P450 1A2 distal site is crucial in the nitric oxide complex stability. J. Biol. Chem. 271, 8570-8574.
28. Lukat-Rodgers, G. S., and Rodgers, K. R. (1997) Characterization of ferrous FixL-nitric oxide adducts by resonance Raman spectroscopy. Biochemistry 36, 4178-4187.
29. Couture, M., Burmester, T., Hankeln, T., and Rousseau, D. L. (2001) The heme environment of mouse neuroglobin. Evidence for the presence of two conformations of the heme pocket. J. Biol. Chem. 276, 36377-36382.
30. Deng, T. J., Proniewicz, L. M., Kincaid, J. R., Yeom, H., Macdonald, I. D., and Sligar, S. G. (1999) Resonance Raman studies of cytochrome P450BM3 and its complexes with exogenous ligands. Biochemistry 38, 13699-13706.
31. Hu, S., and Kincaid, J. R. (1991) Resonance Raman spectra of the nitric oxide adducts of ferrous cytochrome P450cam in the presence of various substrates. J. Am. Chem. Soc. 113, 9760-9766.
32. Voegtle, H. L., Sono, M., Adak, S., Pond, A. E., Tomita, T., Perera, R., Goodin, D. B., Ikeda-Saito, M., Stuehr, D. J., and Dawson, J. H. (2003) Spectroscopic characterization of five-and six-coordinate ferrous-NO heme complexes. Evidence for heme Fe-proximal cysteinate bond cleavage in the ferrous-NO adducts of the Trp-409Tyr/Phe proximal environment mutants of neuronal nitric oxide synthase. Biochemistry 42, 2475-2484.
33. Sohaskey, C. D. (2008) Nitrate enhances the survival of Mycobacterium tuberculosis during inhibition of respiration. J. Bacteriol. 190, 2981-2986.
34. Hendgen-Cotta, U. B., Merx, M. W., Shiva, S., Schmitz, J., Becher, S., Klare, J. P., Steinhoff, H. J., Goedecke, A., Schrader, J., Gladwin, M. T., Kelm, M., and Rassaf, T. (2008) Nitrite reductase activity of myoglobin regulates respiration and cellular viability in myocardial ischemia-reperfusion injury. Proc. Natl. Acad. Sci. U.S.A. 105, 10256-10261.
35. Shiva, S., Huang, Z., Grubina, R., Sun, J., Ringwood, L. A., MacArthur, P. H., Xu, X., Murphy, E., Darley-Usmar, V. M., and Gladwin, M. T. (2007) Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ. Res. 100, 654-661.
36. Lewis, R. S., Tamir, S., Tannenbaum, S. R., and Deen, W. M. (1995) Kinetic analysis of the fate of nitric oxide synthesized by macrophages in vitro. J. Biol. Chem. 270, 29350-29355.
37. Franke, A., Stochel, G., Jung, C., and Van Eldik, R. (2004) Substrate binding favors enhanced NO binding to P450cam. J. Am. Chem. Soc. 126, 4181-4191.
38. Jung, C., Bec, N., and Lange, R. (2002) Substrates modulate the rate-determining step for CO binding in cytochrome P450cam (CYP101). A high-pressure stopped-flow study. Eur. J. Biochem. 269, 2989-2996.
39. Locuson, C. W., Hutzler, J. M., and Tracy, T. S. (2007) Visible spectra of type II cytochrome P450-drug complexes: evidence that "incomplete" heme coordination is common. Drug Metab. Dispos. 35, 614-622.
40. Weichsel, A., Maes, E. M., Andersen, J. F., Valenzuela, J. G., Shokhireva, T., Walker, F. A., and Montfort, W. R. (2005) Heme-assisted S-nitrosation of a proximal thiolate in a nitric oxide transport protein. Proc. Natl. Acad. Sci. U.S.A. 102, 594-599.
41. Igarashi, J., Sato, A., Kitagawa, T., Yoshimura, T., Yamauchi, S., Sagami, I., and Shimizu, T. (2004) Activation of heme-regulated eukaryotic initiation factor 2alpha kinase by nitric oxide is induced by the formation of a five-coordinate NO-heme complex: optical absorption, electron spin resonance, and resonance Raman spectral studies. J. Biol. Chem. 279, 15752-15762.
42. Reynolds, M. F., Parks, R. B., Burstyn, J. N., Shelver, D., Thorsteinsson, M. V., Kerby, R. L., Roberts, G P., Vogel, K M., and Spiro, T. G. (2000) Electronic absorption, EPR, and resonance Raman spectroscopy of CooA, a CO-sensing transcription activator from R. rubrum, reveals a five-coordinate NO-heme. Biochemistry 39, 388-396.
43. Fischmann, T. O., Hruza, A., Niu, X. D., Fossetta, J. D., Lunn, C. A., Dolphin, E., Prongay, A. J., Reichert, P., Lundell, D. J., Narula, S. K., and Weber, P. C. (1999) Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation. Nat. Struct. Biol. 6, 233-242.
44. Crane, B. R., Arvai, A. S., Ghosh, D. K., Wu, C., Getzoff, E. D., Stuehr, D. J., and Tainer, J. A. (1998) Structure of nitric oxide synthase oxygenase dimer with pterin and substrate. Science 279, 2121-2126.
45. Adak, S., Crooks, C., Wang, Q., Crane, B. R., Tainer, J. A., Getzoff, E. D., and Stuehr, D. J. (1999) Tryptophan 409 controls the activity of neuronal nitric-oxide synthase by regulating nitric oxide feedback inhibition. J. Biol. Chem. 274, 26907-26911.
46. Adak, S., Wang, Q., and Stuehr, D. J. (2000) Molecular basis for hyperactivity in tryptophan 409 mutants of neuronal NO synthase. J. Biol. Chem. 275, 17434-17439.
47. Adams, L. B., Dinauer, M. C., Morgenstern, D. E., and Krahenbuhl, J. L. (1997) Comparison of the roles of reactive oxygen and nitrogen intermediates in the host response to Mycobacterium tuberculosis using transgenic mice. Tuberc. Lung Dis. 78, 237-246.
48. MacMicking, J. D., North, R. J., LaCourse, R., Mudgett, J. S., Shah, S. K., and Nathan, C. F. (1997) Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc. Natl. Acad. Sci. U.S.A. 94, 5243-5248.
49. Nicholson, S., Bonecini-Almeida Mda, G., Lapa e Silva, J. R., Nathan, C., Xie, Q. W., Mumford, R., Weidner, J. R., Calaycay, J., Geng, J., Boechat, N., Linhares, C., Rom, W., and Ho, J. L. (1996) Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis. J. Exp. Med. 183, 2293-2302.
50. Gauthier, C., van Faassen, E., Mikula, I., Martasek, P., and Slama-Schwok, A. (2006) Endothelial nitric oxide synthase reduces nitrite anions to NO under anoxia. Biochem. Biophys. Res. Commun. 341, 816-821.
51. Shiro, Y., Fujii, M., Iizuka, T., Adachi, S., Tsukamoto, K., Nakahara, K., and Shoun, H. (1995) Spectroscopic and kinetic studies on reaction of cytochrome P450nor with nitric oxide. Implication for its nitric oxide reduction mechanism. J. Biol. Chem. 270, 1617-1623.
52. Scheele, J. S., Bruner, E., Kharitonov, V. G., Martasek, P., Roman, L. J., Masters, B. S., Sharma, V. S., and Magde, D. (1999) Kinetics of NO ligation with nitric-oxide synthase by flash photolysis and stopped-flow spectrophotometry. J. Biol. Chem. 274, 13105-13110.
53. Abu-Soud, H. M., Wu, C., Ghosh, D. K., and Stuehr, D. J. (1998) Stopped-flow analysis of CO and NO binding to inducible nitric oxide synthase. Biochemistry 37, 3777-3786.